Evidence map›Paper›PMID 15862259›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.

Quanda Liu, Kuansheng Ma, Zhenping He, Jiahong Dong, Xin Hua, Xuequan Huang, Liang Qiao

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02261584 (Comparative Study of Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02261584 naunknown statusnot on this map

Comparative Study of Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism

TypeinterventionalSponsorTanta UniversityRan2014 to 2015Enrolled40ConditionsHypersplenismArmsMicrowave Thermal Coagulation, Partial Splenic Embolization
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Personalized Management of Cytopenias in Chronic Liver Disease: From Pathophysiology to Treatment Strategies.JGH open : an open access journal of gastroenterology and hepatology · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Management of thrombocytopenia in advanced liver disease.Canadian journal of gastroenterology & hepatology · 2014
    Review
  11. A case of splenic abscess after radiofrequency ablation.World journal of gastroenterology · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Quanda LiuInstitute of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, China.
Kuansheng Ma
Zhenping He
Jiahong Dong
Xin Hua
Xuequan Huang
Liang Qiao
Westmead Institute · AUArmy Medical University · CNChinese PLA General Hospital · CNThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiofrequency ablation is a relatively new technique used for local ablation of unresectable tumors. We investigated the feasibility and efficacy of radiofrequency ablation for hypersplenism and its effect on liver function in patients with liver cirrhosis and portal hypertension. Nine consecutive patients with hypersplenism due to cirrhotic portal hypertension underwent radiofrequency ablation in enlarged spleens. The ablation was performed either intraoperatively or percutaneously. Patients are followed up for over 12 months. After treatment, between 20% and 43% of spleen volume was ablated, and spleen volume increased by 4%-10.2%. White blood cell count, platelet count, liver function, and hepatic artery blood flow showed significant improvement after 1-year follow-up. Splenic vein and portal vein blood flow were significantly reduced. Only minor complications including hydrothorax (three of nine patients) and mild abdominal pain (four of nine patients) were observed. No mortality or other morbidity occurred. Radiofrequency ablation is a safe, effective, and minimally invasive approach for the management of splenomegaly and hypersplenism in patients with liver cirrhosis and portal hypertension. Increased hepatic artery blood flow may be responsible for sustained improvement of liver condition. Radiofrequency ablation may be used as a bridging therapy for cirrhotic patients waiting for liver transplantation.

Indexed as

AdultCatheter AblationDiagnostic ImagingFemaleFollow-Up StudiesHumansHypersplenismHypertension, PortalLiver CirrhosisMaleMiddle AgedMinimally Invasive Surgical ProceduresPilot ProjectsProspective StudiesRegional Blood FlowRisk Assessment

Identifiers

PMID15862259
OpenAlexW2070935259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.